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The effect of consecutive days of exercise on
markers of oxidative stress
Cecilia M. Shing, Jonathan M. Peake, Shannon M. Ahern, Natalie A. Strobel,
Gary Wilson, David G. Jenkins, and Jeff S. Coombes
Abstract: We examined the influence of 3 consecutive days of high-intensity cycling on blood and urinary markers of oxi-
dative stress. Eight highly-trained male cyclists (VO2 max 76 ± 4 mLkg–1min–1; mean ± SD) completed an interval session
(9 exercise bouts lasting 30 s each, at 150% peak power output) on day 1, followed by 2 laboratory-simulated 30 km time
trials on days 2 and 3. The cyclists also completed a submaximal exercise trial matched to the interval session for oxygen
consumption. Blood was collected pre- and post-exercise for the determination of malondialdehyde (MDA), total antioxi-
dant status (TAS), vitamin E, and the antioxidant enzyme activity of superoxide dismutase and glutathione peroxidase,
while urine was collected for the determination of allantoin. There were significant increases in plasma MDA concentra-
tions (p < 0.01), plasma TAS (p < 0.01), and urinary allantoin excretion (p < 0.01) following the high-intensity interval
session on day 1, whereas plasma vitamin E concentration significantly decreased (p = 0.028). Post-exercise changes in
plasma MDA (p = 0.036), TAS concentrations (p = 0.039), and urinary allantoin excretion (p = 0.031) were all signifi-
cantly attenuated over the 3 consecutive days of exercise, whereas resting plasma TAS concentration was elevated. There
were no significant changes in plasma MDA, TAS, or allantoin excretion following submaximal exercise and there were
no significant changes in antioxidant enzyme activity over consecutive days of exercise or following submaximal exercise.
Consecutive days of high-intensity exercise enhanced resting plasma TAS concentration and reduced the post-exercise in-
crease in plasma MDA concentrations.
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Re´sume´ : Nous analysons l’effet de 3 se´ances, en autant de jours, d’exercice de forte intensite´ a` ve´lo sur les marqueurs
sanguins et urinaires du stress par oxydation. Huit cyclistes masculins tre`s bien entraıˆne´s (VO2 max 76 ± 4 mLkg–1min–1;
moyenne ± E´ T) participent le jour 1 a` une se´ance d’entraıˆnement par intervalles et re´alisent 9 efforts d’une dure´e de 30 s
a` une intensite´ e´quivalent a` 150 % de leur puissance de pointe produite; aux jours 2 et 3, ils participent en laboratoire a`
deux courses simule´es contre la montre sur une distance de 30 km. Les cyclistes re´alisent aussi un exercice sous-maximal
et consomment la meˆme quantite´ d’oxyge`ne que celle consomme´e au cours de la se´ance d’entraıˆnement par intervalles.
Avant et apre`s la se´ance d’effort, on pre´le`ve des e´chantillons sanguins afin d’analyser le contenu en propanedial (MDA),
le bilan antioxydant global (TAS), la concentration de vitamine E et l’activite´ de la superoxyde dismutase et de la gluta-
thion peroxydase; de plus, on recueille un e´chantillon d’urine pour analyser la concentration d’allantoı¨ne. Le jour 1, on ob-
serve apre`s la se´ance d’entraıˆnement par intervalles une augmentation significative de la concentration plasmatique de
MDA (p < 0,01), du TAS (p < 0,01) et de la concentration urinaire d’allantoı¨ne (p < 0,01), mais on observe aussi une di-
minution de la concentration plasmatique de vitamine E (p = 0,028). Aux jours 1, 2 et 3, on observe apre`s la se´ance
d’exercice une diminution significative de la concentration plasmatique de MDA (p = 0,036) et du TAS (p = 0,039) et de
la concentration urinaire d’allantoı¨ne (p = 0,031); le TAS plasmatique demeure cependant e´leve´ au repos. On n’observe
pas de variations significatives des concentrations plasmatiques de MDA, du TAS et de la concentration urinaire d’allan-
toı¨ne a` la suite de l’effort sous-maximal et on n’observe pas de variations significatives de l’activite´ des enzymes antioxy-
dantes tout au long de ces trois journe´es et a` la suite de l’effort sous-maximal. Des se´ances quotidiennes conse´cutives
constitue´es d’un effort de forte intensite´ augmentent le TAS plasmatique au repos et diminuent la concentration plasma-
tique de MDA apre`s l’effort.
Mots-cle´s : effort a` ve´lo, propanedial, bilan antioxydant global.
[Traduit par la Re´daction]
Introduction
Exercise is associated with an increased production of
free radicals and reactive oxygen species (ROS), and excess
production of ROS has been linked to damage (oxidation) of
lipids, proteins, and DNA through a process termed oxida-
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tive stress (Jenkins and Goldfarb 1993). Lipid peroxidation
of cell membranes changes membrane integrity, leads to in-
creased swelling, and reduces the ability of the cell to main-
tain ion gradients (Merry et al. 1991). This oxidative
damage to cell membranes has been associated with tissue
inflammation, muscle fatigue, and impaired recovery follow-
ing high-intensity exercise (Pyne 1994; Abuja 2001).
Although there is a considerable volume of literature re-
porting the incidence of oxidative stress in trained and un-
trained individuals in response to acute bouts of exercise
(see Konig et al. (2001) for a review), limited research has
investigated the extent of oxidative stress following consec-
utive days of training in moderately to highly trained endur-
ance athletes (Mena et al. 1991; Viguie et al. 1993; Subudhi
et al. 2001) that often train at high intensities for prolonged
periods of time. Many endurance athletes also race over
consecutive days, which may increase their risk of incurring
oxidative damage. Although adaptations to exercise-induced
oxidative stress have been reported following extended
training periods in rats (Criswell et al. 1993; Senturk et al.
2001; Petibois and Deleris 2005) and humans (Ji 2002), it
remains unclear as to whether oxidative defense systems
have the capacity to accommodate the oxidative stress re-
sulting from consecutive days of intense exercise (Viguie et
al. 1993; Okamura et al. 1997). Although the effects of oxi-
dative stress on exercise performance are unclear (Child et
al. 2000), inhibition of lipid peroxidation is associated with
a reduction in muscular fatigue and attenuation of inflamma-
tion (Messina et al. 2006), whereas a decrease in glutathione
oxidation delays muscle fatigue (Matuszczak et al. 2005).
Oxidative stress occurrence and alterations in antioxidant
defenses following exercise may influence subsequent exer-
cise performance and oxidative stress responses over consec-
utive days of training.
The aim of the present investigation was to examine po-
tential changes in urine and hematological markers of oxida-
tive stress and markers of endogenous antioxidant status in
highly trained cyclists over 3 consecutive days of aerobic
and anaerobic exercise to reflect the high-intensity demands
of cyclists’ training. We hypothesized that consecutive days
of high-intensity exercise without dietary intervention would
result in a cumulative increase in oxidative stress and a de-
crease in antioxidant defenses.
Materials and methods
Overview
Following a familiarization visit and determination of
VO2 max, subjects attended the Human Performance Labora-
tory at the University of Queensland for 3 consecutive days
and performed (i) a high-intensity interval session, (ii) a 30
km time trial, and (iii) a second 30 km time trial. Between 4
and 6 days later, subjects performed a submaximal trial in
which total oxygen consumed was equal to that consumed
during the interval session.
Subjects
Eight highly-trained male road cyclists with a VO2 max of
76 ± 4 mLkg–1min–1 (mean ± SD) volunteered to partici-
pate in the study (Table 1). Cyclists had a minimum of 2
years competitive racing experience. All cyclists refrained
from taking any dietary or vitamin supplements 1 month
prior to and for the duration of the study. They completed a
medical history questionnaire and gave their written consent
to participate; the study was approved by an ethics commit-
tee at The University of Queensland. For all visits, cyclists
reported to the laboratory in a fasted and rested state. They
had abstained from strenuous exercise for 36 h prior to the
first day of consecutive high-intensity training and before
the final submaximal trial. Four highly active males with
VO2 max of 60 ± 6 mLkg–1min–1 volunteered to participate
as control subjects (Table 1). Highly trained male cyclists
were unable to be obtained as control subjects, as they
would have had to refrain from training for 4 consecutive
days, which conflicted with their training schedules. The
control subjects agreed to refrain from taking any dietary or
vitamin supplements 1 month prior to and for the duration
of the study. In addition to completing a medical history
questionnaire and giving their written consent to participate,
they were required to abstain from exercise for a period of 4
days. Rested and fasted blood samples were taken at the
same time of day on days 2, 3, and 4. This coincided with
blood sampling of the exercising subjects over the 3 consec-
utive days of high-intensity exercise.
Familiarization
A familiarization visit required cyclists to complete a 30
min submaximal ride with the equipment (mouthpiece,
headgear, and cycle ergometer) used in the VO2 max test.
During this visit cyclists also completed 3 high-intensity in-
terval bouts (30 s at 620 W) to familiarize them with the in-
tensity of the interval session.
VO2 max testing
Cyclists exercised to fatigue on an electronically braked
cycle ergometer (Lode Excalibur Sport, Quinton) modified
with clip-in pedals and low-profile racing handlebars; the
saddle and handle bar positions of the cycle ergometer were
adjusted to resemble each cyclists’ own bike, and subjects
warmed up at a self-selected pace for 5 min. The incremen-
tal test commenced at an initial workload of 100 W; work-
load thereafter increased by 15 W every 30 s until volitional
fatigue. Oxygen consumption and carbon dioxide production
were measured continuously, and data were recorded by a
Lab View Computer Program (South Australian Sports Insti-
tute). Expired air was analyzed for fractions of expired oxy-
gen (FEO2) and carbon dioxide (FECO2) every 15 s during
exercise (Ametek gas analyzers; SOV S-3A11 and COV
CD3A, Pittsburgh, PA), and minute ventilation (VE) was re-
corded every 15 s using a turbine ventilometer (Morgan,
Model 096, Kent, England). The gas analyzers were cali-
brated immediately before and validated after each test us-
ing a certified beta gas mixture (Commonwealth Industrial
Gas Ltd., Brisbane, Australia); the ventilometer was cali-
brated before and validated after each test using a 1 L sy-
ringe in accordance with the manufacturer’s instructions.
VO2 max was assumed when two of the following conditions
occurred: (i) the oxygen consumption ceased to increase
linearly with a rising workload and approached a plateau
or dropped slightly, the last two values agreeing within ±
2 mLkg–1min–1; (ii) 90% of age-predicted maximum heart
rate (HRmax) was attained; and (iii) respiratory exchange
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ratio (RER) was greater than 1.10. VO2 max was recorded as
the highest VO2 value averaged over two consecutive read-
ings, and the peak power output was recorded as the high-
est 30 s power output completed during the incremental
test.
High-intensity interval session
Between 4 and 6 days following the VO2 max test cyclists
completed the high-intensity interval session. They per-
formed nine 30 s bouts at 150% of peak power output; 4.5
min of low-intensity exercise (cycling at 50 W) separated
each bout (exercise time was comparable with the time to
complete the 30 km time trial). The cyclists exercised on
the electronically braked cycle ergometer, and oxygen up-
take was monitored for the entire session (i.e., during the ex-
ercise and recovery periods). One minute prior to the
commencement of each interval, subjects could remove their
mouthpiece to consume water. Oxygen consumption from
the previous 30 s reading and the 30 s reading following
water intake were averaged to estimate oxygen consumption
for the 30 s period during which the mouthpiece was re-
moved. The amount of water consumed by cyclists in each
of the 4 testing sessions was between 400 and 500 mL. To-
tal oxygen consumption was determined during the high-
intensity interval session. Oxidative stress variables were
compared between the high-intensity interval session and
the point during the submaximal ride at which total oxygen
consumption (and energy expenditure) was the same.
Time trials
Two laboratory simulated 30 km time trials were com-
pleted by the cyclists on days 2 and 3; exercise was per-
formed by each cyclist on his own bicycle that was
mounted to a stationary windtrainer (Cateye, Cyclosimulator
CS-1000, Japan). The rear tire was inflated to 120 psi (1 psi =
6.89 10–3 Pa), and placed gently against the friction de-
vice before it was secured; the spring-loaded release brake
was removed and a wind-regulated friction load was placed
against the rear wheel. Each cyclists’ same rear wheel was
used for both 30 km time trials. Performance time was
blinded to the subject during the 30 km time trial, but was
revealed to him on completion of the trial.
Submaximal ride
Between 4 and 6 days following the second 30 km time
trials, cyclists completed a submaximal ride during which
the exercise intensity and duration were calculated to ensure
that total oxygen consumed was equal to the total oxygen
consumed during the interval session. Each cyclists’ own
road bicycle was mounted to a stationary windtrainer, in the
same manner as described for the 30 km time trials. Cyclists
were able to observe their speed (kmh–1) and oxygen con-
sumption was monitored every 7 min (for 3 min intervals)
throughout the ride to ensure that the cyclists were riding at
the required oxygen consumption.
Dietary analysis
Both cyclists and control subjects recorded their food in-
take for a 24 h period prior to all experimental testing ses-
sions. Diet was analyzed using Foodworks Professional
(Xyris Software, Australia), which provided information on
energy intake in addition to macro- and micro-nutrient in-
take.
Urine collection
Urine was collected pre- and post-exercise for the high-
intensity interval session, both 30 km time trials, and the
submaximal session. Each cyclist was instructed to empty
his bladder 1 h prior to arriving at the laboratory. He then
immediately consumed 250 mL of water. Ten minutes prior
to exercise, after arrival at the laboratory, each cyclist was
again instructed to empty his bladder. Urine was again col-
lected from 0 to 30 min post-exercise. All samples were col-
lected by voluntary voiding in a container provided to the
subject. Urine (40 mL) was acidified with 600 mL of 1 mol/
L H2SO4 and stored at –20 8C for later analysis.
Urinary allantoin
Allantoin was measured in urine because, once produced,
it is cleared into the urine relatively quickly (Benzie et al.
1999; Hellsten et al. 1997; Mikami et al. 2000). The assay
for determination of urinary allantoin concentration was de-
veloped using a combination of previously published meth-
ods by Shingfield and Offer (1999) and Grootveld and
Halliwell (1987) with the following modifications. Urine
samples were extracted with acetonitrile and added to hex-
ane. They were placed in a freezer at –80 8C for 10 min to
enable the aqueous phase to freeze. The mixture was then
removed from the freezer and the hexane phase poured off
and discarded, while the remaining aqueous phase was left
to thaw. The thawed mixture was then evaporated using a
Thermo Savant speed vacuum (SPD 111v) set at a temper-
ature of 35 8C for a period of 30 min, after which it was
reconstituted with formic acid prior to processing.
The concentrations of allantoin in extracted samples were
determined by liquid chromatography – mass spectrometry
(LC/MS) using a gradient high-performance liquid chroma-
tography (HPLC) system (Shimadzu LC-10AT system, Ja-
pan) coupled to a triple quadruple mass spectrometer
(Perkin Elmer Sciex API 3000) operating in single ion mon-
itoring mode with positive ion electrospray. Each sample
was analyzed for the presence of allantoin (extraction peak
at 159.1 molecular weight). A C18 column (5 mm, 50 
2.0 mm) (Phenomenex) was used for reverse-phase HPLC
at a flow rate of 0.2 mLmin–1. The mobile phase used in
the initial 6 min isocratic stage of each run was solvent A
(0.1% formic acid in water). This isocratic stage was fol-
Table 1. Subject characteristics.
Age (y) Mass (kg) Height (cm) VO2 max (mLkg–1min–1) PPO (W)
Highly trained (n = 8) 25 (4) 67.7 (6.2) 176.4 (6.7) 75.6 (4.1) 433 (37)
Control (n = 4) 25 (1) 68.0 (2.5) 175 (6.9) 60.7 (6.3) 401 (38)
Note: PPO, peak power output. Data are presented as mean ± SD.
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lowed by a 3 min washing – re-equilibrating cycle that in-
volved taking solvent A to 80% solvent B (0.1% formic
acid in 90% acetonitrile – water) for 2 min and then chang-
ing back to 100% solvent A for 1 min. A 10 mL injection of
each sample was analyzed. Recovery of spiked samples was
91.3% and the interassay coefficient of variation was 4.5%.
Allantoin is released rapidly from muscle to blood in re-
sponse to the non-enzymatic oxidation of urate and is then
cleared into the urine relatively quickly (Benzie et al. 1999;
Hellsten et al. 1997; Mikami et al. 2000). Allantoin was ex-
pressed relative to the volume of urine produced and not
corrected for creatinine, as the relationship between creati-
nine and allantoin excretion is weak at high allantoin con-
centrations.
Blood collection
Fasted blood samples (10 mL) were drawn from an ante-
cubital vein into heparinized vacutainers; blood was taken
10 min before and 5 min after exercise. Hematocrit was de-
termined in duplicate by microcentrifugation of blood in mi-
crotubes and hemoglobin was measured using standard
techniques (Drabkin 1965). The change in plasma volume
was calculated according to the method of Dill and Costill
(1974).
Collected blood was centrifuged at 1500g for 10 min at
4 8C. The plasma was collected and stored at –80 8C until
later analysis. Two millilitres of red blood cells were
washed with 20 mL of cold buffer (50 mmol/L Tris–HCl
(pH 7.6), 5 mmol/L ethylenediaminetetraacetic acid,
1 mmol/L dithiothreitol) and again centrifuged at 1500g for
10 min at 4 8C. The supernatant was then removed and dis-
carded and the red blood cells were lysed in 4 times their
volume of ice-cold ddH2O (1 mL red blood cells to 4 mL
ddH2O). This mixture was then centrifuged (1500g for
10 min at 4 8C) and the remaining supernatant collected
and frozen at –80 8C until later analysis.
Vitamin E
Plasma concentrations of vitamin E (a-tocopherol), total
carotenoids, and total free cholesterol were determined by
reverse-phase HPLC using the liquid–liquid extraction
method of (Taibi and Nicotra 2002). Briefly, proteins were
precipitated with Ethanol:BHT (200 gL–1), followed by a
hexane lipid extraction. After separation of the precipitated
protein, 700 mL hexane was speed dried (Savant RVT400
and Savant SpeedVac SPDIIIV, Holbrook, NY, USA) and
reconstituted with 100 mL methanol. Total carotenoids and
vitamin E were mearsured using fluorometric detection and
electrochemical detection for total cholesterol via injection
of 40 mL into a LiChrospher C18 column (250  4 mm,
5 mm; Merck, Darmstadt, Germany), with a flow rate of
0.8 mLmin–1 and 10.3 MPa backpressure. Separate stock
solutions of dl-a-tocopherol (Fluka, Buchs, Switzerland)
and lycopene and a- and b-carotene for total carotenoids
and cholesterol (Sigma, St. Louis, Mo.) were used as exter-
nal standards.
Malondialdehyde
HPLC was used to determine plasma malondialdehyde
(MDA) using the method of Sim et al. (2003). The principle
of this method is that malondialdehyde contained in plasma
is derivatized with 2,4-dinitrophenylhydrazine, which forms
stable hydrazones that can be easily separated by HPLC us-
ing diode array detection (Shimadzu, Kyoto, Japan).
Total antioxidant status
Total antioxidant status was determined by the method of
Miller et al. (1993), which is based on the inhibition by anti-
oxidants of the absorbance of the radical cation 2,2’-azinobis
(3-ethylbenzthiazoline-6-sulfonate) (ABTS+). This radical
cation is formed by the interaction of ABTS with the ferryl-
myoglobin radical species, generated by the activation of
metmyoglobin with hydrogen peroxide. Antioxidant com-
pounds suppress the absorbance of the ABTS+ radical cation
to an extent and on a time scale dependent on the antioxi-
dant capacity of the plasma. The assay was carried out on a
Cobas Mira automated spectrophotometer (Roche Diagnos-
tics, Basel, Switzerland). Plasma total antioxidant status was
corrected for changes in plasma volume.
Antioxidant enzymes
Erythrocyte glutathione peroxidase (GPX) and superoxide
dismutase (SOD) activities were determined according to the
methods of Wheeler et al. (1990) and Madesh and Balasu-
bramanian (1998), respectively. The assays were modified
to be performed on the Cobas Mira spectrophotometer. All
enzyme activities were normalized to haemoglobin concen-
tration.
Statistical analysis
All statistical analyses were performed using SPSS ver-
sion 10.0 for Windows (SPSS, Chicago, Ill.). Data was first
tested for normality using the Kolmogorov–Smirnov and
Shapiro–Wilk tests. To examine the effects of the 3 consec-
utive days of training a time (pre- and post-exercise)  trial
(day 1, day 2, and day 3) repeated-measures analysis of var-
iance (ANOVA) and an ANOVA for the absolute change in
values over the 3 days was used with p < 0.05 as significant.
When a significant main effect was found, differences be-
tween trials were determined using the multiple-comparison
false-discovery rate procedure (Curran-Everett 2000). The
false-discovery rate was set at p < 0.05 (Table 2). Compari-
sons were significant when the p value determined from a t
test was less than the calculated critical value. In addition,
percentage changes and effect sizes (ES) for the difference
between pre- and post-exercise means were calculated. ES
was interpreted as follows: 0.2 = small, 0.5 = moderate, and
0.8 = large; these terms are used in the results section
(Thomas et al. 1991).
Results
The primary aim of this study was to investigate the
changes in markers of oxidative stress and antioxidant de-
fenses after consecutive days of exercise in highly trained
cyclists. There were no significant differences between the
control group and the exercising group for VO2 max, peak
power output, height, weight, or age (p > 0.05). There were
no significant differences for any of the control group meas-
ures over the experimental period (p > 0.05) (Fig. 1). Diet-
ary macro- and micro-nutrient intakes were similar for each
exercise trial (p > 0.05), and there were no significant differ-
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ences for pre-exercise measures for the interval session and
submaximal trial (average exercise intensity of 58%
VO2 max) for the experimental group (p > 0.05).
There was a significant time  trial interaction for plasma
MDA concentration over the 3 days of high-intensity exer-
cise (p = 0.046). The magnitude of the post-exercise in-
crease in plasma MDA concentration across the 3 days was
also significantly different (ES = 0.6, p = 0.036). Post-
exercise plasma MDA concentration was significantly in-
creased for the high-intensity interval session (18%, ES =
1.1) (Table 2). There was also a significant increase in
plasma MDA concentration after the 30 km time trial 1 on
day 2 (16%, ES = 0.8); however, the post-exercise increase
for 30 km time trial 2 on day 3 was not significant (4%, ES =
0.3) (Fig. 2a). Pre-exercise MDA concentrations were sig-
nificantly elevated on day 2 (ES = 1.0), but returned to
baseline values on day 3 of the consecutive days of high-
intensity exercise. Post-exercise MDA concentrations were
not significantly increased for the submaximal session
(3.3%, ES = 0.4) (Fig. 2a).
There was a significant main effect of time on urinary al-
lantoin excretion over the 3 consecutive days of exercise (p =
0.031) (Fig. 2b). There was a large significant post-exer-
cise increase in urinary allantoin excretion for the interval
session on day 1 (171%, ES = 1.7). However, there were
no significant increases in urinary allantoin excretion for
30 km time trial 1 on day 2 (38%, ES = 0.2) or 30 km
time trial 2 on day 3 (23%, ES = 0.1). The magnitude of
the change in urinary allantoin excretion was significantly
reduced across the 3 consecutive days of high-intensity
training (p < 0.01). There was a large post-exercise in-
crease in urinary allantoin concentration following the sub-
maximal session; however, this increase was not significant
(61%, ES = 1.1).
Plasma TAS concentrations were significantly elevated
post-exercise following the interval session on day 1
(13.4%, ES = 1.8) and both 30 km time trials on days 2 and
3 (8.3%, ES = 1.1 and 5.5%, ES = 0.7;, respectively) (p <
0.001). There was also a significant decrease in the magni-
tude of post-exercise change in plasma TAS concentrations
after exercise over the 3 consecutive days of high-intensity
training (p = 0.039). Compared with pre-exercise values on
day 1, pre-exercise plasma TAS was significantly elevated
on days 2 (ES = 0.6) and 3 (ES = 0.8) of the consecutive
days of high-intensity exercise (Fig. 3). There was no signif-
icant increase in plasma TAS concentration following the
submaximal session (1.3%, ES = 0.2).
Plasma vitamin E concentration was significantly de-
creased post-exercise on day 1 of consecutive days of high-
intensity exercise (–10.1%, ES = 0.7); however, there were
no significant changes detected between trials over the 3
consecutive days of exercise or following the submaximal
trial (1.8%, ES = 0.1) (Fig. 4). Erythrocyte GPX and SOD
activities remained unchanged following each exercise trial
(Fig. 5).
Discussion
The aim of the present study was to determine the influ-
ence of consecutive days of high-intensity exercise on
markers of oxidative stress and antioxidant status in highly-
trained cyclists. Post-exercise increases in biomarkers of ox-
idative stress were reduced over 3 consecutive days of in-
tense exercise, whereas resting plasma TAS concentrations
were elevated on days 2 and 3. Although intense exercise
may increase lipid peroxidation, urate oxidation, and plasma
TAS, such alterations are not necessarily accompanied by
changes in erythrocyte antioxidant activity.
Lipid peroxidation, as indicated by plasma MDA concen-
tration, increased significantly after the interval session and
the second day of high-intensity training (i.e., first 30 km
time trial). Although both the interval session and the 30
km time trial on day 2 elevated post-exercise plasma MDA
concentration, there was no increase for the 30 km time trial
performed on day 3. Lovlin et al. (1987) investigated the re-
lationship between exercise intensity and lipid peroxidation
in moderately-trained males (VO2 max = 47 mLkg–1min–1)
and found that at exercise intensities of 40% and 70%
VO2 max there was no evidence of oxidative stress assessed
from MDA. Exercise intensity on days 2 and 3 of the con-
secutive days was comparable to 79% VO2 max, thereforeit
appears that the decrease in MDA concentration on day 3
was not related to a decrease in exercise intensity.
In the same pattern as plasma MDA concentrations, uri-
nary allantoin excretion was reduced over the 3 consecutive
days of high-intensity exercise. Allantoin is produced from
the non-enzymatic oxidation of urate and elevated resting
concentrations of urinary allantoin have been associated
Table 2. Calculations for false-discovery rate procedure.
TAS Allantoin MDA
Comparison p value Critical value p value Critical value p value Critical value
pre-IS vs. post-IS 0.000 0.033* 0.001 0.033* 0.002 0.017*
pre-TT301 vs. post-TT301 0.003 0.008* 0.521 0.042 0.016 0.033*
pre-TT302 vs. post-TT302 0.011 0.025* 0.723 0.050 0.214 0.008
pre-SM vs. post-SM 0.218 0.050 0.054 0.050 0.234 0.050
pre-IS vs. pre-TT301 0.011 0.017* 0.162 0.025 0.003 0.042*
pre-IS vs. pre-TT302 0.026 0.033* 0.392 0.033 0.035 0.033
post-IS vs. post-SM 0.005 0.017* 0.000 0.017* 0.031 0.033*
post-IS vs. post-TT301 0.611 0.050 0.040 0.017 0.078 0.025
post-IS vs. post-TT302 0.611 0.042 0.015 0.008 0.126 0.017
Note: False-discovery rate set at 0.05. TAS, total antioxidant status; MDA, malondialdehyde; SM, submaximal; IS, interval session; TT30, 30 km
time trial. p value = achieved significance level from t test.
*Denotes significance (p value < critical value).
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with oxidative stress conditions such as diabetes and rheu-
matoid arthritis (Benzie et al. 1999). Allantoin was signifi-
cantly increased following the interval session on day 1;
however, there was no increase in response to the 30 km
time trial on days 2 and 3. It remains unknown whether al-
lantoin excretion was unchanged following both 30 km time
trials in response to an upregulation of TAS from exercise
on day 1, either owing to a decrease in the availability of
urate as a substrate or as the result of unchanged levels of
urate oxidation. Although allantoin excretion was not signif-
icantly increased following the submaximal trial, there was a
large effect of exercise (ES = 1.1) when compared with days
2 and 3 of the consecutive days of exercise. Allantoin has
been produced following exercise at 100% and 90%
VO2 max, but not at 40% VO2 max (Mikami et al. 2000). In
the present study, there was a large (61%, ES = 1.1) post-
exercise increase in allantoin excretion following submaxi-
mal exercise (average intensity of 58% VO2 max); however,
the post-exercise increase following the 30 km time trial on
days 2 and 3 (average intensity of 79% VO2 max) was small
(38%, ES = 0.2 and 23%, ES = 0.1, respectively). Post-exer-
cise allantoin excretion following exercise on days 2 and 3,
which was at a greater intensity than during the submaximal
trial, may have been reduced as a result of adaptations to ex-
ercise on day 1. The reduction in urinary allantoin concen-
trations observed with consecutive days of training may
indicate a decrease in ROS production, or a greater contribu-
tion of antioxidants other than urate to scavenge ROS.
The progressive decline in markers of oxidative stress
over 3 consecutive days of exercise may reflect a reduction
in the production of ROS, an up-regulation and (or) adapta-
tion of antioxidant defense mechanisms, or a decrease in
substrate availability. Post-exercise plasma TAS concentra-
tions were elevated following exercise on day 1 and resting
plasma concentrations were elevated on days 2 and 3. This
upregulation of plasma antioxidants may represent a positive
adaptation to consecutive days of high-intensity training. A
major contributor to the total antioxidant activity of plasma
is the antioxidant activity of urate (Subudhi et al. 2001). The
amount of urate present in vivo prior to exercise has been
shown to influence the extent of ROS production and reduce
lipid peroxidation following cycling to fatigue (approx. 10–
18 min) (Green and Fraser 1988; Mikami et al. 2000).
Although we did not measure plasma urate, previous reports
indicate the plasma urate concentration is elevated 40% for
24 h following intermittent sprint cycle training at 120%
VO2 max (Green and Fraser 1988), which was an intensity
lower than the interval session on day 1 in the present study.
The increase in TAS concentration in the present study on
days 2 and 3 may have contributed to a reduction in lipid
peroxidation, as indicated by the reduced magnitude of
post-exercise MDA concentration over the 3 consecutive
days of high-intensity exercise. In contrast to the present
findings, levels of lipid peroxidation following a half mara-
thon have remained unchanged despite higher resting levels
of plasma total antioxidant capacity (Child et al. 2000). The
amount of protection against lipid peroxidation offered by
elevated pre-exercise urate levels may be influenced by ex-
ercise duration.
Although plasma TAS concentrations were not depleted,
vitamin E concentrations following the interval session
were significantly reduced when compared with the submax-
imal exercise trial (–10.1% vs. 1.8%, respectively). Previous
research has shown a decrease in plasma vitamin E concen-
tration following a 30 s cycle sprint (Hutler et al. 2001) and
a decrease in response to maximal treadmill exercise (Viguie
et al. 1993; Vasankari et al. 1997). Following submaximal
exercise, studies have reported either an increase or no
Fig. 1. Control subjects’ variables over 3 consecutive non-exercising days. (A) Malondialdehyde (MDA). (B) Total antioxidant status
(TAS). (C) Vitamin E. (D) Glutathione peroxidase (GPX). (E) Superoxide dismutase (SOD). Data are mean ± SEM.
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change in plasma vitamin E concentration (Burton et al.
1983). Together, with the present findings, these data sug-
gest that a high-intensity interval session may more readily
deplete vitamin E when compared with a 30 km time trial,
to protect against increased oxidative stress. Vitamin E is
an important component of the lipid membrane and offers
protection against lipid peroxidation (Duthie et al. 1990; Du-
faux et al. 1997; Marzatico et al. 1997; Groussard et al.
2003). The decrease in plasma vitamin E following the in-
terval session may have contributed to the increased suscept-
ibility of lipids to peroxidation following the same trial, as
indicated by the increase in plasma MDA concentration.
Plasma MDA concentrations were, however, significantly
elevated following the 30 km time trial on day 2, whereas
plasma vitamin E levels were unchanged. The protective
role of endogenous vitamin E in preventing lipid peroxida-
tion at varying exercise intensities requires further investiga-
tion.
Reports of alterations in erythrocyte antioxidant enzyme
activity after exercise are equivocal (Duthie et al. 1990). In
the present study, erythrocyte GPX and SOD activities did
Fig. 2. Plasma malondialdehyde concentration (A) and urinary al-
lantoin excretion (B) pre- and post-exercise. Day 1, interval ses-
sion; day 2, 30 km time trial 1; day 3, 30 km time trial 2; SM,
submaximal. Data are mean ± SEM. Asterisk (*) denotes signifi-
cantly different versus pre-exercise, p < 0.01. Dagger ({) indicates
that the change from pre- to post-exercise was significantly differ-
ent between interval and SM sessions. Double dagger ({) indicates
a significant difference between pre-exercise values.
Fig. 3. Plasma total antioxidant status pre- and post-exercise. Day
1, interval session; day 2, 30 km time trial 1; day 3, 30 km time
trial 2; SM, submaximal. Data are mean ± SEM. Asterisk (*) de-
notes significantly different versus pre-exercise. Dagger ({) indi-
cates that the change from pre- to post-exercise was significantly
different between interval and SM sessions. Double dagger ({) in-
dicates significant difference between pre-exercise values.
Fig. 4. Plasma vitamin E pre- and post-exercise. Day 1, interval
session: day 2, 30 km time trial 1; day 3, 30 km time trial 2; SM,
submaximal. Data are mean ± SEM. Asterisk (*) denotes signifi-
cantly different versus pre-exercise.
Fig. 5. Antioxidant enzyme activities pre- and post-exercise for
each trial. (A) Glutathione peroxidase (GPX). (B) Superoxide dis-
mutase (SOD). Data are mean ± SEM.
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not change in response to 3 consecutive days of high-inten-
sity exercise or submaximal exercise. These findings are
consistent with those of Duthie et al. (Subudhi et al. 2001),
who found no change in erythrocyte GPX, catalase, or SOD
activities in 7 highly trained males immediately and 5 d fol-
lowing a half-marathon. GPX activity has also remained un-
changed over a period of land and snow training in elite
alpine skiers (Tauler et al. 1999). In contrast to the present
findings, previous research showed increased GPX activity
in trained athletes both immediately and during 60 min of
recovery following a duathlon race (Tauler et al. 1999).
SOD activity has also been reported to increase following a
2800 km, 20 d road race (Mena et al. 1991). It is possible
that the duration of exercise in the present study may not
have been sufficient to alter erythrocyte antioxidant enzyme
activities.
Data from the present investigation suggest that although
oxidative stress occurs following the initial days of high-
intensity exercise, there is no cumulative effect of succes-
sive days of high-intensity exercise on the oxidation of
lipids and protein in highly trained cyclists. TAS remains
elevated for 24 h following high-intensity intermittent exer-
cise and may offer protection against subsequent oxidative
stress over consecutive days of high-intensity training.
Although intense exercise may increase lipid peroxidation,
urate oxidation, and plasma TAS, such alterations are not
necessarily accompanied by changes in erythrocyte antioxi-
dant activity. As antioxidant defenses were not depleted,
highly-trained cyclists appear to have antioxidant defense
systems that cope with ROS production associated with 3
consecutive days of high-intensity training. Mechanisms
that offer additional protection from oxidative stress during
the initial days of consecutive days of high-intensity exer-
cise, such as antioxidant supplementation that may enhance
plasma TAS levels and plasma vitamin E levels, require fur-
ther investigation.
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